MDS Virtual Congress 2021 Archives - Page 59 of 132

Gut dysbiosis in Parkinson’s disease with motor complications

K. Takahashi, H. Nishiwaki, M. Ito, K. Iwaoka, K. Yamahara, K. Takahashi, Y. Suzuki, K. Taguchi, Y. Tsuboi, K. Kashihara, M. Hirayama, K. Ohno, T. Maeda (Shiwa, Japan)
Gut microbiota and nutritional profiles of Parkinson’s disease patients.

M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)
Gut microbiota in patients with Parkinson’s disease (PD) predicts disease progression better than clinical features

H. Nishiwaki, M. Ito, T. Hamaguchi, T. Maeda, K. Kashihara, Y. Tsuboi, M. Masahisa, M. Hirayama, K. Ohno (Nagoya City, Japan)
Gut, nasal and oral dysbiosis in Parkinson’s disease

S. Jo, W. Kang, YS. Hwang, SH. Lee, SJ. Chung (Seoul, Republic of Korea)
Happy to be home: Satisfaction with interdisciplinary home visits among individuals with advanced Parkinson’s Disease and their caregivers

J. Fleisher, K. Woo, M. Levin, S. Hess, F. Akram, B. Ouyang, D. Hall, J. Chodosh (Chicago, USA)
HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson’s disease and type 2 diabetes.

B. Huxford, T. Haque, A. Joseph, C. Simonet, D. Gallagher, C. Budu, R. Dobson, A. Noyce (London, United Kingdom)
Health instruction in Parkinson’s disease with an emphasis on the quality of life using eHealth strategies in the context of COVID-19

J. Biernaski, S. Souza, D. Baptista, M. Borato, N. Cuduh, J. Pelegrini, A. Silva, V. Israel (Curitiba, Paraná, Brazil)
Healthcare utilization in individuals with late onset versus adult-onset Huntington’s disease

J. Ta, TM. To, A. Patel, I. Abbass, S. Arndorfer, R. Ghandy (South San Francisco, USA)
Hearing Impairment was not associated with Dream Enactment Behavior and Parkinsonism in the Population: a CLSA Prospective Study

C. Yao, A. Szpindel, A. Pelletier, R. Postuma (Montréal, Canada)
Hemi-chorea Due to Celiac Disease

M. Cincotta, M. Spindler (Philadelphia, USA)